Mohammed Imran Khan

29PUBLICATIONS
57CO-AUTHORS
Medical biochemistry and metabolomics not elsewhere classifiedCross-sectional analysisPredictive and prognostic markersEpigenetics (incl. genome methylation and epigenomics)Nanotoxicology, health and safety
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Jul 28, 2026
Correction: Shait Mohammed et al. Profiling the Effect of Targeting Wild Isocitrate Dehydrogenase 1 (IDH1) on the Cellular Metabolome of Leukemic Cells. Int. J. Mol. Sci. 2022, 23, 6653.

|Jul 24, 2026
Montelukast Versus Gabapentin for Uremic Pruritus in Twice-Weekly Hemodialysis Patients: A 52-Week Prospective Non-Randomized Open-Label Comparative Study.

|May 27, 2026
A Vascular-Extracellular Matrix Molecular Program Identifies High-Risk Diffuse Glioma Across Independent Multi-Omics.

|Feb 27, 2026
TUBB2A and TM4SF1 Methylation Define Prognostic Subgroups in Adult-Type Diffuse Glioma.

Tarek Arabi, Itika Arora, Arshiya Akbar

|Jan 28, 2026
Correction: Alzahrani et al. Urolithin A and B Alter Cellular Metabolism and Induce Metabolites Associated with Apoptosis in Leukemic Cells. Int. J. Mol. Sci. 2021, 22, 5465.

Abdulaziz Musa Alzahrani, Mohammed Razeeth Shait Mohammed, Raed Ahmed Alghamdi

|Jul 29, 2024
Deciphering KDM8 dysregulation and CpG methylation in hepatocellular carcinoma using multi-omics and machine learning.

Firoz Ahmed, Nitish Kumar Mishra, Othman A Alghamdi

Pageof 5

Frequent Collaborators

11 joint publications

Hani Choudhry

8 joint publications

Mohammed Razeeth Shait Mohammed

6 joint publications

Faisal Alzahrani

4 joint publications

Salman Hosawi